Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients

Bone Marrow Transplantation volume 39, pages 315–316 (2007)Cite this article

We report two cases of human parvovirus B19 infection as a rare but anticipated complication shortly after allogeneic peripheral blood stem cell transplantation (PBSCT), which were self-limiting in their course.

The first patient was a 48-year-old female treated for secondary acute myeloid leukaemia (AML) FAB M2 following chemotherapy for breast cancer 7 years ago. She received a PBSCT in second complete remission, from a matched unrelated donor, after conditioning with 2 Gy total-body irradiation, 120 mg/m2 fludarabine, 60 mg/kg cyclophosphamide and 30 mg/kg antithymocyte globulin. Immunosuppressive therapy was initiated with cyclosporine and mycofenolate. One day before transplantation, the patient presented with sudden skin erythema, which soon resolved without any treatment. On day 10 after PBSCT, she developed an erythematous itchy eruption of the skin on both arms and the neck line, initially reminiscent of acute graft-versus-host disease (aGvHD), but subsequently very inconsistent in its appearance in that it migrated from the neck line to the abdomen and back and finally to both legs. This lasted for a period of 14 days. Our differential diagnosis included early acute cutaneous GvHD, viral erythema and drug-induced erythema. The latter seemed unlikely as no new drug had been administered. To clarify the diagnosis a skin biopsy was taken. Surprisingly, this turned out to be positive for parvovirus B19 upon polymerase chain reaction (PCR), as was a bone marrow aspirate (700 copies/ml) taken at the same time. PCR from skin samples were not analysed quantitatively. Histology did not show any signs suggestive of GvHD but a nonspecific pattern of inflammation with distinct signs of cytotoxicity, as is frequently seen in skin lesions because of viral infections. Blood was positive for parvovirus B19 immunoglobin G (IgG) before transplantation. Findings were negative for parvovirus B19 IgM before, during and after the infection. Parvovirus B19 PCR in peripheral blood was also negative during and after the infection.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ang HA, Apperley JF, Ward KN . Persistence of antibody to human parvovirus B19 after allogeneic bone marrow transplantation: role of prior recipient immunity. Blood 1997; 89: 4646–4651.

    CAS  PubMed  Google Scholar 

  2. Brown KE, Young NS . Parvovirus B19 infection and hematopoiesis. Blood Rev 1995; 9: 176–182.

    Article  CAS  Google Scholar 

  3. Solano C, Juan O, Gimeno C, Garcia-Conde J . Engraftment failure associated with peripheral blood stem cell transplantation after B19 parvovirus infection. Blood 1996; 88: 1515–1517.

    CAS  PubMed  Google Scholar 

  4. Heegaard ED, Petersen BL . Parvovirus B19 transmitted by bone marrow. Br J Haematol 2000; 111: 659–661.

    Article  CAS  Google Scholar 

  5. Plentz A, Hahn J, Knöll A, Holler E, Jilg W, Modrow S . Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 2005; 45: 1811–1815.

    Article  Google Scholar 

  6. Bonvicini F, Gallinella G, Gentilomi GA, Ambretti S, Musiani M, Zerbini M . Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination. Clin Lab 2006; 52: 263–268.

    PubMed  Google Scholar 

  7. Eid AJ, Brown RA, Patel R, Razonable RR . Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 2006; 43: 40–48.

    Article  Google Scholar 

  8. Hayes-Lattin B, Seipel TJ, Gatter K, Heinrich MC, Maziarz RT . Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation. Am J Hematol 2004; 75: 142–145.

    Article  Google Scholar 

  9. Mouthon L, Guillevin L, Tellier Z . Intravenous immunglobulins in autoimmune- or parvovirus B19 pure red cell aplasia. Autoimmun Rev 2005; 4: 264–269.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine IV, Bone Marrow Transplantation Section, Hematology and Oncology, State Center for Cell and Gene Therapy, Martin-Luther-University Halle-Wittenberg, Halle, Germany

    A Muetherig, M Christopeit, L P Müller, W Grothe, T Weber, S Theurich & G Behre

Authors
  1. A Muetherig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Christopeit
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L P Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W Grothe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Theurich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G Behre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Behre.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muetherig, A., Christopeit, M., Müller, L. et al. Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients. Bone Marrow Transplant 39, 315–316 (2007). https://doi.org/10.1038/sj.bmt.1705589

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705589

This article is cited by

Search

Advanced search

Quick links